| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | |
Filed by the Registrant ☑ | | | Filed by a Party other than the Registrant ☐ |
Check the appropriate box: | |||
☐ | | | Preliminary Proxy Statement |
☐ | | | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☑ | | | Definitive Proxy Statement |
☐ | | | Definitive Additional Materials |
☐ | | | Soliciting Material under §240.14a-12 |
Proto Labs, Inc. |
(Name of Registrant as Specified In Its Charter) |
(Name of Person(s) Filing Proxy Statement if other than the Registrant) |
Payment of Filing Fee (Check the appropriate box): | ||||||
☑ | | | No fee required. | |||
☐ | | | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
| | (1) | | | Title of each Class of securities to which transaction applies: | |
| | |||||
| | (2) | | | Aggregate number of securities to which transaction applies: | |
| | |||||
| | (3) | | | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |
| | |||||
| | (4) | | | Proposed maximum aggregate value of transaction: | |
| | |||||
| | (5) | | | Total fee paid: | |
| | | | |||
☐ | | | Fee paid previously with preliminary materials. | |||
| | | | |||
☐ | | | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. | |||
| | | | |||
| | (1) | | | Amount previously paid: | |
| | |||||
| | (2) | | | Form, Schedule or Registration Statement No.: | |
| | |||||
| | (3) | | | Filing Party: | |
| | |||||
| | (4) | | | Date Filed: | |
| |
| Proto Labs, Inc. will hold its 2020 Annual Meeting of Shareholders online via live webcast on Tuesday, May 19, 2020 at www.virtualshareholdermeeting.com/PRLB20. The Annual Meeting will begin at 8:30 a.m. central time. The proxy materials were made available to you via the Internet or mailed to you beginning on or about April 6, 2020. | | ||||||
| TIME AND DATE: | | | 8:30 a.m. Central Time, on Tuesday, May 19, 2020 | | |||
| ITEM OF BUSINESS: | | | At the Annual Meeting, our shareholders will: | | |||
| | | 1. | | | Elect eight directors to hold office until the next Annual Meeting of Shareholders or until their successors are duly elected. | | |
| | | 2. | | | Vote on the ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2020. | | |
| | | 3. | | | Vote on an advisory basis to approve the compensation of the officers disclosed in the accompanying Proxy Statement, which we refer to as a “say-on-pay” vote. | | |
| | | 4. | | | Vote on an advisory basis to approve the frequency of the Company’s future “say-on-pay” votes, which we refer to as a “say-when-on-pay” vote. | | |
| | | 5. | | | Act on any other matters that may properly come before the Annual Meeting, or any adjournment or postponement thereof. | | |
| RECOMMENDATION: | | | The board of directors recommends that shareholders vote FOR each of the following: | | |||
| | | 1. | | | The director nominees named in the accompanying Proxy Statement. | | |
| | | 2. | | | The ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2020. | | |
| | | 3. | | | The approval of the say-on-pay proposal. | | |
| | | | The board of directors recommends that shareholders vote ONE YEAR on the following: | | |||
| | | 4. | | | The say-when-on-pay proposal. | | |
| Only shareholders of record at the close of business on March 24, 2020 may vote at the Annual Meeting or any adjournment or postponement thereof. | | ||||||
| | | | | By Order of the Board of Directors | | ||
| | | | | ![]() | | ||
| | | | | Jason Frankman Secretary | |
| PROXY SUMMARY | |
| Name | | | Age | | | Director Since | | | Independent | | | Audit Committee | | | Compensation Committee | | | Nominating and Governance Committee | |
| Victoria M. Holt | | | 62 | | | 2014 | | | No | | | | | | | | |||
| Archie C. Black | | | 58 | | | 2016 | | | Yes | | | | | ![]() | | | | ||
| Sujeet Chand | | | 62 | | | 2017 | | | Yes | | | | | ![]() | | | ![]() | | |
| Moonhie Chin | | | 62 | | | 2019 | | | Yes | | | | | | | | | ||
| Rainer Gawlick | | | 52 | | | 2008 | | | Yes | | | ![]() | | | ![]() | | | | |
| John B. Goodman | | | 60 | | | 2001 | | | Yes | | | ![]() | | | | | ![]() | | |
| Donald G. Krantz | | | 65 | | | 2017 | | | Yes | | | | | | | | |||
| Sven A. Wehrwein | | | 69 | | | 2011 | | | Yes | | | ![]() | | | | | ![]() | |
![]() | | | Chairperson | |
![]() | | | Member | |
• | Separate Board Chairperson and CEO |
• | Risk oversight by full Board and Committees |
• | Majority voting standard for uncontested director elections |
• | Annual election of directors |
• | By-laws provide for Proxy Access by shareholders |
• | Annual advisory say-on-pay vote |
• | Achievement – Speed and innovation are the cornerstones of our success. We are committed to being a solution for getting things done quickly and a catalyst for great ideas for our shareholders, customers and each other. We are responsible for our performance, our results and our future. |
• | Teamwork – We are dedicated to the idea that more minds are better than one. Through open communication, we strive to collaborate with our colleagues to maximize our creativity and to make our good ideas great. We respect each other’s opinions. We help colleagues who are struggling to improve, so our success is everyone’s success. |
• | Trust – Our integrity is built on honest answers to our customers and colleagues. It is okay to make mistakes if we use them to learn. We navigate difficult situations with compassion. The success of our company depends on the success of our people. |
| | | Proposal | | | Board's Voting Recommendation | | |
| 1. | | | Election of the eight director nominees named in this Proxy Statement to serve for one-year terms. | | | For | |
| 2. | | | Ratification of the selection of the independent accounting firm. | | | For | |
| 3. | | | Advisory vote on executive officer compensation. | | | For | |
| 4. | | | Advisory vote on the frequency of the Company's future say-when-on-pay votes. | | | One Year | |
Q: | Who can vote? |
A: | You can vote if you were a shareholder at the close of business on the record date of March 24, 2020 (the “Record Date”). There were a total of 26,675,192 shares of our common stock outstanding on the Record Date. The Notice of Internet Availability of Proxy Materials (the “Notice”), notice of annual meeting, this Proxy Statement and accompanying proxy card and the Annual Report on Form 10-K for 2019 were first mailed or made available to you beginning on or about April 6, 2020. This Proxy Statement summarizes the information you need to vote at the Annual Meeting. |
Q: | Who can attend the Annual Meeting? |
A: | This year, the 2020 Annual Meeting will be conducted exclusively virtually via live webcast at www.virtualshareholdermeeting.com/PRLB20, (the “Annual Meeting Website”), in a fashion similar to our prior in-person meetings. For the first time, all shareholders, regardless of size, resources or physical location, eligible to attend the 2020 Annual Meeting will be able to participate via webcast and will be able to communicate with us and ask questions before and during the Meeting. All shareholders as of the Record Date, or their duly appointed proxies, may attend the Annual Meeting. If you hold your shares in street name, then you must request a legal proxy from your broker or nominee to attend and vote at the Annual Meeting. |
Q: | What am I voting on? |
A: | You are voting on: |
• | Election of eight nominees as directors to hold office until the next Annual Meeting of Shareholders or until their successors are duly elected. |
• | Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2020. |
• | Approval on an advisory basis of the compensation of our officers disclosed in this Proxy Statement, which we refer to as a “say-on-pay” vote. |
• | Approval on an advisory basis of the frequency of future say-on-pay votes, which we refer to as a “say-when-on-pay” vote. |
Q: | How does the board of directors recommend I vote on the proposals? |
A: | The board is soliciting your proxy and recommends you vote: |
• | FOR the director nominees; |
• | FOR the ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2020; |
• | FOR the say-on-pay proposal; and |
• | ONE YEAR for the say-when-on-pay proposal. |
Q: | Why did I receive a notice in the mail regarding the Internet availability of proxy materials instead of a paper copy of the proxy materials? |
A: | “Notice and Access” rules adopted by the United States Securities and Exchange Commission (the “SEC”) permit us to furnish proxy materials, including this Proxy Statement and our Annual Report on Form 10-K for 2019, to our shareholders by providing access to such documents on the Internet instead of mailing printed copies. Shareholders will not receive printed copies of the proxy materials unless they request them. Instead, the Notice will instruct you as to how you may access and review all of the proxy materials on the Internet. The Notice also instructs you as to how you may submit your proxy on the Internet. If you would like to receive a paper or email copy of our proxy materials, you should follow the instructions for requesting such materials in the Notice. Any request to receive proxy materials by mail will remain in effect until you revoke it. |
Q: | How many shares must be voted to approve each proposal? |
A: | Quorum. A majority of the shares entitled to vote, represented in person or by proxy, is necessary to constitute a quorum for the transaction of business at the Annual Meeting. As of the Record Date, 26,675,192 shares of our common stock were issued and outstanding. A majority of those shares will constitute a quorum for the purpose of electing directors and adopting proposals at the Annual Meeting. If you submit a valid proxy or attend the Annual Meeting, your shares will be counted to determine whether there is a quorum. |
Q: | What is the effect of broker non-votes and abstentions? |
A: | A “broker non-vote” occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have or does not exercise discretionary voting power with respect to that item and has not received voting instructions from the beneficial owner. If a broker returns a “non-vote” proxy indicating a lack of authority to vote on a proposal, then the shares covered by such a “non-vote” proxy will be deemed present at the Annual Meeting for purposes of determining a quorum, but not present for purposes of calculating the vote with respect to any non-discretionary proposals. Nominees will not have discretionary voting power with respect to any matter to be voted upon at the Annual Meeting, other than the ratification of the selection of our independent registered public accounting firm. Broker non-votes will have no effect on the election of directors, the ratification of the independent registered accounting firm, approval of the advisory say-on-pay resolution, approval of the advisory say-when-on-pay resolution, or any other item properly presented at the Annual Meeting. |
Q: | How will the proxies vote on any other business brought up at the Annual Meeting? |
A: | By submitting your proxy, you authorize the proxies to use their judgment to determine how to vote on any other matter brought before the Annual Meeting, or any adjournments or postponements thereof. We do not know of any other business to be considered at the Annual Meeting. The proxies’ authority to vote according to their judgment applies only to shares you own as the shareholder of record. |
Q: | How do I cast my vote? |
A: | If you are a shareholder whose shares are registered in your name, you may vote using any of the following methods: |
• | Internet. You may vote by going to the web address www.proxyvote.com 24 hours a day, seven days a week, until 11:59 p.m. Eastern Time on May 18, 2020 and following the instructions for Internet voting shown on your proxy card. |
• | Telephone. If you requested printed proxy materials and you received a paper copy of the proxy card, you may vote by dialing 1-800-690-6903 24 hours a day, seven days a week, until 11:59 p.m. Eastern Time on May 18, 2020 and following the instructions for telephone voting shown on your proxy card. |
• | Mail. If you requested printed proxy materials and you receive a paper copy of the proxy card, then you may vote by completing, signing, dating and mailing the proxy card in the envelope provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. If you vote by Internet or telephone, please do not mail your proxy card. |
• | Virtually at the Annual Meeting Website. If you are a shareholder whose shares are registered in your name, you may vote virtually via live webcast at www.virtualshareholdermeeting.com/PRLB20. |
Q: | Can I vote my shares by filling out and returning the Notice? |
A: | No. The Notice identifies the items to be voted on at the Annual Meeting, but you cannot vote by marking the Notice and returning it. The Notice provides instructions on how to vote by Internet, by requesting and returning a paper proxy card or voting instruction card, or by voting at the Annual Meeting. |
Q: | Can I revoke or change my vote? |
A: | You can revoke your proxy at any time before it is voted at the Annual Meeting by: |
• | submitting a new proxy with a more recent date than that of the first proxy given before 11:59 P.M. Eastern Time on May 18, 2020 by (1) following the Internet voting instructions or (2) following the telephone voting instructions; |
• | completing, signing, dating and returning a new proxy card to us, which must be received by us before the time of the Annual Meeting; or |
• | participating in the virtual Annual Meeting and revoking the proxy by voting those shares when joining the meeting. |
Q: | Who will count the votes? |
A: | Broadridge Financial Solutions, Inc., our independent proxy tabulator, will count the votes. John Way, our Chief Financial Officer, will act as inspector of election for the Annual Meeting. |
Q: | Is my vote confidential? |
A: | All proxies and all vote tabulations that identify an individual shareholder are confidential. Your vote will not be disclosed except: |
• | To allow Broadridge Financial Solutions, Inc. to tabulate the vote; |
• | To allow John Way to certify the results of the vote; and |
• | To meet applicable legal requirements. |
Q: | What shares are included on my proxy? |
A: | Your proxy will represent all shares registered to your account in the same social security number and address. |
Q: | What happens if I don’t vote shares that I own? |
A: | For shares registered in your name. If you do not vote shares that are registered in your name by voting online at the Annual Meeting or by proxy through the Internet, telephone or mail, your shares will not be counted in determining the presence of a quorum or in determining the outcome of the vote on the proposals presented at the Annual Meeting. |
Q: | What if I do not specify how I want my shares voted? |
A: | If you are a registered shareholder and submit a signed proxy card or submit your proxy by Internet or telephone but do not specify how you want to vote your shares on a particular matter, we will vote your shares as follows: |
• | FOR all of the director nominees; |
• | FOR the ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2020; and |
• | FOR the say-on-pay proposal. |
• | ONE YEAR for the say-when-on-pay proposal. |
Q: | What does it mean if I get more than one Notice or proxy card? |
A: | Your shares are probably registered in more than one account. You should provide voting instructions for all Notices and proxy cards you receive. |
Q: | How many votes can I cast? |
A: | You are entitled to one vote per share on all matters presented at the Annual Meeting or any adjournment or postponement thereof. There is no cumulative voting. |
Q: | When are shareholder proposals and nominees due for the 2021 Annual Meeting of Shareholders? |
A: | If you want to submit a shareholder proposal or nominee for the 2021 Annual Meeting of Shareholders, you must submit the proposal in writing to our Secretary, Proto Labs, Inc., 5540 Pioneer Creek Drive, Maple Plain, Minnesota 55359, so it is received by the relevant dates set forth below under “Submission of Shareholder Proposals and Nominations.” |
Q: | What is “householding”? |
A: | We may send a single Notice, as well as other shareholder communications, to any household at which two or more shareholders reside unless we receive other instruction from you. This practice, known as “householding,” is designed to reduce duplicate mailings and printing and postage costs, and conserve natural resources. If your Notice is being householded and you wish to receive multiple copies of the Notice, or if you are receiving multiple copies and would like to receive a single copy, or if you would like to opt out of this practice for future mailings, you may contact: |
Q: | How is this proxy solicitation being conducted? |
A: | We will pay for the cost of soliciting proxies and we will reimburse brokerage houses and other custodians, nominees and fiduciaries for their reasonable out-of-pocket expenses for forwarding proxy and solicitation materials to our shareholders. In addition, some of our employees may solicit proxies. We may solicit proxies in person, via the Internet, by telephone and by mail. Our employees will not receive special compensation for these services, which the employees will perform as part of their regular duties. |
• | each person or group who is known by us to own beneficially more than 5% of our outstanding shares of common stock; |
• | each of our named executive officers named in the Summary Compensation Table below; |
• | each of our directors and each director nominee; and |
• | all of the executive officers, directors and director nominees as a group. |
| Name and Address of Beneficial Owner | | | Beneficial Ownership on March 24, 2020 | | |||
| Greater than 5% shareholders: | | | Number | | | Percent | |
| BlackRock, Inc. | | | | | | ||
| 55 East 52nd Street | | | | | | ||
| New York, NY 10055 | | | 4,163,973(1) | | | 15.6% | |
| | | | | | |||
| Brown Capital Management, LLC | | | | ||||
| 1201 N. Calvert Street | | | | ||||
| Baltimore, MD 21202 | | | 3,788,628(2) | | | 14.2% | |
| | | | | | |||
| The Vanguard Group | | | | ||||
| 100 Vanguard Blvd. | | | | ||||
| Malvern, PA 19355 | | | 2,681,946(3) | | | 10.1% | |
| | | | | | |||
| Riverbridge Partners LLC | | | | ||||
| 80 South Eighth St., Suite 1200 | | | | ||||
| Minneapolis, MN 55402 | | | 1,510,317(4) | | | 5.7% | |
| | | | | | |||
| Directors and named executive officers: | | | | ||||
| Archie C. Black | | | 7,112(5) | | | * | |
| Sujeet Chand | | | 5,547 (6) | | | * | |
| Moonhie Chin | | | 990 | | | * | |
| Rainer Gawlick | | | 29,117 (7) | | | * | |
| John B. Goodman | | | 13,389 (8) | | | * | |
| Donald Krantz | | | 5,547 (9) | | | * | |
| Sven A. Wehrwein | | | 24,006 (10) | | | * | |
| Victoria M. Holt | | | 75,268 (11) | | | * | |
| John A. Way | | | 39,713 (12) | | | * | |
| Arthur R. Baker III | | | 20,207 (13) | | | * | |
| Robert Bodor | | | 28,493 (14) | | | * | |
| Bjoern Klaas | | | 1,957 (15) | | | * | |
| David M. Fein | | | — | | | * | |
| All directors and executive officers as a group (13 persons) | | | 244,234 (16) | | | * | |
* | Represents beneficial ownership of less than one percent |
(1) | Information is based on a Schedule 13G/A filed with the SEC by BlackRock, Inc. (“BlackRock”) on February 4, 2020. BlackRock has sole voting power over 4,116,330 shares of our common stock and sole dispositive power over 4,163,973 shares of our common stock. |
(2) | Information is based on a Schedule 13G/A filed with the SEC by Brown Capital Management LLC (“Brown”) on February 14, 2020. Brown has sole voting power over 2,407,390 shares of our common stock and sole dispositive power over 3,788,628 shares of our common stock. |
(3) | Information is based on a Schedule 13G/A filed with the SEC by Vanguard Group Inc. (“Vanguard”) on February 12, 2020. Vanguard has sole voting power over 57,175 shares of our common stock, shared voting power over 5,901 shares of our common stock, sole dispositive power over 2,622,527 shares of our common stock and shared dispositive power over 59,419 shares of our common stock. |
(4) | Information is based on a Schedule 13G/A filed with the SEC by Riverbridge Partners LLC (“Riverbridge”) on February 5, 2020. Riverbridge has sole voting power over 1,142,835 shares of our common stock and sole dispositive power over 1,510,317 shares of our common stock. |
(5) | Includes 1,311 shares of deferred stock units that vest on May 16, 2020 and will be settled after separation from service on the board of directors. |
(6) | Includes 1,311 shares of deferred stock units that vest on May 16, 2020 and will be settled after separation from service on the board of directors. |
(7) | Includes 8,436 shares that Dr. Gawlick has the right to acquire from us within 60 days of the date of the table pursuant to the exercise of stock options and 1,311 shares of deferred stock units that vest on May 16, 2020 and will be settled after separation from service on the board of directors. |
(8) | Includes 1,311 shares of deferred stock units that vest on May 16, 2020 and will be settled after separation from service on the board of directors. |
(9) | Includes 1,311 shares of restricted stock units that vest on May 16, 2020. |
(10) | Includes 10,817 shares that Mr. Wehrwein has the right to acquire from us within 60 days of the date of the table pursuant to the exercise of stock options and 1,311 shares of deferred stock units that vest on May 16, 2020 and will be settled after separation from service on the board of directors. |
(11) | Includes 43,915 shares that Ms. Holt has the right to acquire from us within 60 days of the date of the table pursuant to the exercise of stock options. |
(12) | Includes 23,380 shares that Mr. Way has the right to acquire from us within 60 days of the date of the table pursuant to the exercise of stock options. |
(13) | Includes 8,605 shares that Mr. Baker has the right to acquire from us within 60 days of the date of the table pursuant to the exercise of stock options and 821 shares of restricted stock units that vest on May 4, 2020. |
(14) | Includes 13,529 shares that Dr. Bodor has the right to acquire from us within 60 days of the date of the table pursuant to the exercise of stock options. |
(15) | Includes 534 shares that Mr. Klaas has the right to acquire from us within 60 days of the date of the table pursuant to the exercise of stock options. |
(16) | Includes 109,216 shares held by our executive officers and directors, in the aggregate, that can be acquired from us within 60 days of the date of the table pursuant to the exercise of stock options, 6,555 shares of deferred stock units, in the aggregate, that vest on May 16, 2020 and will be settled after separation from service on the board of directors, 821 shares of restricted stock units that vest on May 4, 2020 and 1,311 shares of restricted stock units that vest on May 16, 2020. |
• | presides at all meetings of the board of directors, including executive sessions of the independent directors; |
• | conducts the annual performance review of the Chief Executive Officer, with input from the other independent directors; |
• | sets the board agenda and frequency of meetings, in consultation with the committee chairs as applicable; and |
• | has the authority to convene meetings of the independent directors at every meeting. |
| Audit Committee | | | Compensation Committee | | | Nominating and Governance Committee | |
| Sven A. Wehrwein (chair) | | | Rainer Gawlick (chair) | | | John B. Goodman (chair) | |
| Rainer Gawlick | | | Archie C. Black | | | Sujeet Chand | |
| John B. Goodman | | | Sujeet Chand | | | Sven A. Wehrwein | |
| Audit Committee | | | Compensation Committee | | | Nominating and Governance Committee | |
| Sven A. Wehrwein (chair) | | | Rainer Gawlick (chair) | | | Sujeet Chand (chair) | |
| Rainer Gawlick | | | Archie C. Black | | | Moonhie Chin | |
| John B. Goodman | | | John B. Goodman | | | Sven A. Wehrwein | |
• | oversees management’s processes for ensuring the quality and integrity of our consolidated financial statements, our accounting and financial reporting processes, and other financial information provided by us to any governmental body or to the public; |
• | evaluates the qualifications, independence and performance of our independent auditor and internal audit function; |
• | oversees the resolution of any disagreements between management and the auditors regarding financial reporting; |
• | oversees our investment and cash management policies; and |
• | supervises management’s processes for ensuring our compliance with legal, ethical and regulatory requirements as set forth in policies established by our board of directors. |
• | identifies qualified individuals to become board members, consistent with criteria approved by the board; |
• | selects director nominees for the next Annual Meeting of Shareholders; |
• | determines the composition of the board’s committees and evaluates and enhances the effectiveness of the board and individual directors and officers; |
• | develops and implements the corporate governance guidelines for our company; and |
• | ensures that succession planning takes place for critical senior management positions. |
• | reviews and approves compensation programs, awards and employment arrangements for executive officers; |
• | administers compensation plans for employees; |
• | reviews our programs and practices relating to leadership development and continuity; and |
• | determines the compensation of non-employee directors. |
| ![]() Victoria M. Holt - Age 62 Director since 2014 | Ms. Holt has served as our President and Chief Executive Officer since February 2014. Prior to joining us, Ms. Holt served as President and Chief Executive Officer of Spartech Corporation, a leading producer of plastic sheet, compounds and packaging products, from September 2010 until Spartech was purchased by PolyOne Corporation in March 2013. Ms. Holt also is a member of the Board of Directors of Waste Management, Inc., a publicly traded company and Piper Sandler Companies, a publicly traded company. Ms. Holt’s leadership, strategic planning, operational and international experience provide valuable insights to our board of directors. As Chief Executive Officer, she also is responsible for determining our strategy, articulating priorities and managing our continued growth. | |
| ![]() Archie C. Black - Age 58 Director since 2016 | Mr. Black has served as a director of our company since March 2016 and serves as a member of the compensation committee. Since 2001, Mr. Black has served as the President and Chief Executive Officer of SPS Commerce, Inc., a provider of cloud-based supply chain management solutions. Mr. Black also serves on the Board of Directors of SPS Commerce, Inc., a publicly traded company. Prior to joining SPS Commerce, Inc., Mr. Black was a Senior Vice President and Chief Financial Officer at Investment Advisors, Inc. Prior to his time at Investment Advisors, Inc., Mr. Black spent three years at Price Waterhouse. Mr. Black is qualified to serve on our board because of his extensive management, financial, and operational experience at SPS Commerce, Inc., during which he led the transformation of a tech-driven startup company into a global business and developed a deep knowledge of the requirements involved with being a public company. | |
| ![]() Sujeet Chand - Age 62 Director since 2017 | Dr. Chand has served as a director of our company since May 2017 and serves as a member of the compensation committee and the nominating and governance committee. Mr. Chand has been the Senior Vice President and Chief Technology Officer at Rockwell Automation, Inc. since 2005. Prior to taking on his current role, Mr. Chand served in various leadership positions at Rockwell. Mr. Chand has sat on multiple government, industry, and higher education advisory boards, and has long had significant interaction with the Board of Directors of Rockwell. Beginning in 2019, Mr. Chand began serving on the board of Flowserve Corporation, a publicly traded company. Mr. Chand earned a Doctor of Philosophy degree in electrical and computer engineering and a master's degree in electrical engineering from the University of Florida. Mr. Chand’s qualifications to serve on our board of directors include, among other skills and qualifications, his deep technical expertise and industry knowledge, particularly his experience at Rockwell. Mr. Chand brings a highly effective balance of strategic insight and technical engineering skills, as well as a unique perspective on technology, innovation and customer needs. He has served on the boards of the National Institute for Standards and Technology (NIST), National Electrical Manufacturers Association (NEMA), FIRST Robotics, Wisconsin Technology Council, University of Wisconsin Foundation, and Robert W. Baird Venture Partners. He has also represented the U.S. as the head of a delegation to Intelligent Manufacturing Systems, a worldwide consortium on manufacturing technology. | |
| ![]() Moonhie Chin - Age 62 Director since 2019 | Ms. Chin has served as a director of our company since August 2019. She served most recently as Senior Vice President of Digital Platform and Experience at Autodesk, Inc., a global leader in design, construction and entertainment software with more than 200 million customers. Her expertise extends to general management, business model transformation from perpetual license to subscription, digital platforms, extracting business insights from advanced analytics, global multi-channel models, global customer support and operations, strategic planning and corporate governance. She served in multiple key leadership positions at Autodesk from 1989 to 2019. Ms. Chin has an exceptional track record of unifying organizations around a mission, incubating and driving new initiatives to optimize business efficiencies and applying intellectual rigor to solve complex challenges. She is a recognized mentor to emerging leaders, especially women in technology, and is interested in leadership opportunities that promote a culture of excellence, positive team dynamics, and personal and professional development. | |
| ![]() Rainer Gawlick - Age 52 Director since 2008 | Dr, Gawlick has served as a director of our company since September 2008 and serves as a member of the audit committee and as the chair of the compensation committee. Dr. Gawlick also serves on the boards of Chyronhego, Cloudsense, SingleDigits and Progress, a publicly traded company, where he is a member of the compensation committee and the audit committee. Previously, from July 2015 to October 2016, Dr. Gawlick was President of Perfecto Mobile, Ltd., a leader in mobile testing. Prior to that he was with IntraLinks, Inc. where he was Executive Vice President of Global Sales. IntraLinks, Inc. is a computer software company providing virtual data rooms and other content management services. From August 2008 to April 2012, Dr. Gawlick served as Chief Marketing Officer of Sophos Ltd, a computer security company providing endpoint, network and data protection software. From April 2005 to August 2008, Dr. Gawlick served as Vice President of Worldwide Marketing and Strategy at SolidWorks Corp., a CAD software company. He also has held a variety of executive positions in other technology businesses and was a consultant with McKinsey & Company. Dr. Gawlick has extensive sales, marketing and product-management experience in the technology industry. Dr. Gawlick offers expertise in building brand awareness, managing marketing on a global scale and developing growth strategies, which enables him to counsel our company on its global expansion. | |
| ![]() John B. Goodman - Age 60 Director since 2001 | Mr. Goodman has served as a director of our company since 2001 and serves as a member of the audit committee and as chair of the nominating and governance committee. Mr. Goodman currently serves on the board of directors of Inclined Biomedical Technologies, Inc. d/b/a Dribank Labs. From December 1982 to October 2010, Mr. Goodman held various positions at Entegris, Inc., a materials supplier, most recently as Senior Vice President and Chief Technology & Innovation Officer. Mr. Goodman’s technical background and experiences in supply chain networks, logistics and financial planning and reviews enable Mr. Goodman to provide guidance and counsel on our strategic plan, research and development, supplier relationships and finance functions. | |
| ![]() Donald G. Krantz - Age 65 Director since 2017 | Dr. Krantz is currently an associate at Digi Labs, a Wayzata-based technology incubator. He serves on the advisory board for Activated Research Company, a maker of catalysis-based instruments. Dr. Krantz served as our Executive Vice President and Technology Officer from January 2015 until his retirement in June 2016. From January 2007 to January 2015, Dr. Krantz served as our Chief Operating Officer. From November 2005 to January 2007, Dr. Krantz served as our Vice President of Development. Prior to joining our company, Dr. Krantz served in various roles at MTS Systems, Inc., a builder of custom precision testing and advanced manufacturing systems, including as a business unit Vice President, Vice President of Engineering, and most recently, Chief Technology Officer. Dr. Krantz was an Engineering Fellow at Alliant Techsystems and Honeywell, Inc., and was named the 2005 Distinguished Alumnus of the Department of Computer Science and Engineering at the University of Minnesota. In 2016, he was named a “Titan of Technology” by the Minneapolis/St. Paul Business Journal. Dr. Krantz has knowledge of and experience in leadership positions within multiple departments of our company, as well as his education and experience, enable him to provide guidance and counsel on strategy, relationships, general business matters and risk management. | |
| ![]() Sven A. Wehrwein - Age 69 Director since 2011 | Mr. Wehrwein has served as a director of our company since June 2011 and serves as Chairman, as chair of the audit committee, and as a member of the nominating and governance committee. Mr. Wehrwein has been an independent financial consultant to emerging companies since 1999. During his 35-plus years in accounting and finance, Mr. Wehrwein has experience as a certified public accountant (inactive), investment banker to emerging growth companies, chief financial officer, and audit committee chair. He currently serves on the board of directors of SPS Commerce, Inc., a publicly traded supply-chain management software company, and Atricure, Inc., a publicly traded medical device company. Mr. Wehrwein also served on the board of directors of Compellent Technologies, Inc. from 2007 until its acquisition by Dell Inc. in 2011, on the board of Vital Images, Inc. from 1997 until its acquisition by Toshiba Medical in 2011, on the board of Synovis Life Technologies, Inc. from 2004 until its acquisition by Baxter International, Inc. in 2012, on the board of Cogentix Medical, Inc. from 2006 to 2016, and on the board of Image Sensing Systems, Inc. from 2006 to 2012. Mr. Wehrwein’s qualifications to serve on our board of directors include, among other skills and qualifications, his capabilities in financial understanding, strategic planning and auditing expertise, given his experiences in investment banking and in financial leadership positions. As chairman of the audit committee, Mr. Wehrwein also keeps the board abreast of current audit issues and collaborates with our independent auditors and senior management team. | |
| THE BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE “FOR” EACH NOMINEE LISTED. | |
• | Victoria M. Holt, our President and Chief Executive Officer, or CEO; |
• | John A. Way, our Chief Financial Officer, or CFO, and Executive Vice President of Development; |
• | Arthur R. Baker III, our Chief Technology Officer; |
• | Robert Bodor, our Vice President/General Manager – Americas; |
• | Bjoern Klaas, our Vice President/General Manager and Managing Director – Europe, Middle East and Africa; and |
• | David M. Fein, our Former Chief Revenue Officer whose employment with us terminated effective May 31, 2019. |
| Growth | | | Profitability | | | Cash Generation | |
| +2.9% Revenue increased to $458.7 million in 2019 compared with $445.6 million in 2018. | | | $2.35 Diluted earnings per share was $2.35 in 2019. | | | $116.1m Cash generated from operations during the year totaled $116.1 million. | |
| Topic | | | Actions / Decision | | |||
| 2019 Salary Adjustments | | | ✔ | | | Adjusted salaries for each of our named executive officers to better reflect competitive market levels | |
| 2019 Annual Incentives and Long-Term Incentives | | | ✔ | | | Awarded annual incentives to our named executive officers that averaged 41.8% of their target awards reflecting corporate, and regional where applicable, performance | |
| | | ✔ | | | Added additional 15% incentive payment component to the annual incentive program for 2019 relating to a critical software project to which the named executive officers, along with company employees in the United States and EMEA, were devoting their efforts. This 15% additional incentive payment component is included in the 41.8 average incentive disclosed above. | | |
| | | ✔ | | | Adjusted the annual incentive award calculation to extend the calculation below the threshold amount for revenue and AOI | | |
| | | ✔ | | | Granted our named executive officers 2019 equity awards comprised of stock options, restricted stock units (“RSUs”) and performance stock units (“PSUs”) | |
| Topic | | | Actions / Decision | | |||
| Annual Incentive Program Performance Metrics and Design | | | ✔ | | | Continued the use of revenue and adjusted operating income (“AOI”) as the two key financial metrics in our Annual Incentive Program | |
| | | ✔ | | | Capped the annual incentive plan payouts for 2019 at 200% of the target incentive award | | |
| PSU Performance Metrics | | | ✔ | | | Continued the use of organic revenue growth and adjusted Earnings Per Share (“EPS”) growth as the two performance metrics for our PSU awards | |
| Expansion of Clawback Policy | | | ✔ | | | Expanded our clawback policy to cover misconduct resulting in either a violation of law or company policy that has caused significant financial or reputational harm to the company | |
| Severance Arrangements | | | ✔ | | | Removed a reduction in annual long-term incentive value as a trigger for good reason termination from our severance agreements with our named executive officers other than Ms. Holt. | |
| Benchmarking | | | ✔ | | | Reviewed and approved a new compensation peer group | |
| Things We Do | | | Things We Don’t Do | | ||||||
| • | | | “Double-trigger” treatment for cash and accelerated equity vesting upon a change in control | | | • | | | No tax gross-ups on perquisites, severance or change-in-control payments | |
| • | | | Meaningful stock ownership guidelines for our CEO and executive officers | | | • | | | No hedging/pledging of Proto Labs stock by executive officers | |
| • | | | Requirement that executive officers hold 100% of after-tax shares from option exercises or RSU/PSU vesting until they have achieved their ownership requirement | | | • | | | No option repricing without shareholder approval | |
| • | | | Compensation recoupment (“clawback”) policy | | | • | | | No additional perquisites unique to named executive officers | |
| • | | | Equity award approval policy | | | | | | ||
| • | | | Independent compensation committee | | | | | | ||
| • | | | Independent compensation consultant | | | | | | ||
| • | | | Annual compensation risk assessment | | | | | |
• | Focus on total compensation for purpose of understanding the competitiveness of executive officer compensation |
• | Structure the compensation program so as to align the interests of our executive officers with those of our customers, employees, and shareholders; |
• | Provide a competitive total compensation opportunity that includes target incentive goals that are reasonably achievable and aligned to long-term objectives; |
• | Utilize equity-based awards in a manner designed to motivate long-term company performance, increase shareholder value and emphasize their long-term retentive function; |
• | Recognize and reward the achievement of company and business unit goals as well as individual performance; |
• | Provide compensation commensurate with the level of business performance achieved; |
• | Provide greater compensation opportunities for individuals who have the most significant responsibilities and therefore the greatest ability to influence our achievement of strategic and operational objectives; |
• | Structure the compensation program so that it is understandable and easily communicated to executives, shareholders and other constituencies; |
• | Place increasing emphasis on incentive/variable compensation for positions of increasing responsibility; and |
• | Make benefit programs available to executive officers consistent with those provided to salaried employees. |
| 3D Systems Corporation Axon Enterprise, Inc.* Cognex Corporation* Ellie Mae, Inc. ESCO Technologies, Inc. | | | FARO Technologies, Inc. GrafTech International Ltd.* Monolithic Power Systems, Inc.* Power Integrations, Inc. Raven Industries, Inc. | | | RBC Bearings Incorporated Shutterstock, Inc. SPS Commerce, Inc. Sun Hydraulics Corporation Universal Display Corp. | |
| | | Annual Revenue(1) | | | Market Capitalization(1) | | |
| 25th percentile | | | $369 million | | | $1.6 billion | |
| 75th percentile | | | $665 million | | | $4.3 billion | |
| Proto Labs | | | $372 million | | | $3.5 billion | |
(1) | Amounts shown in this table are for the twelve-month period ended as of the most recently disclosed quarter prior to the 2018 meeting at which Pearl Meyer presented the peer group information to the compensation committee. |
| Compensation Component | | | Form of Compensation | | | Purpose | | |||
| Base Salary | | | Cash | | | • | | | Compensate each named executive officer relative to individual responsibilities, experience and performance | |
| | | | | • | | | Provide steady cash flow not contingent on short-term variations in company performance | | ||
| Annual Incentive | | | Cash | | | • | | | Align compensation with our annual corporate financial performance | |
| | | | | • | | | Reward achievement of short-term financial objectives | | ||
| | | | | • | | | Provide participants with a meaningful total cash compensation opportunity (base salary plus annual incentive) | | ||
| Long-Term Incentives | | | Stock Options, Restricted Stock Units and Performance Stock Units | | | • | | | Align compensation with our long-term returns to shareholders | |
| | | • | | | Encourage long-term retention | | ||||
| | | • | | | Create a long-term performance focus | | ||||
| | | • | | | Provide executive ownership opportunities | |
| Name | | | 2019 Annual Base Salary | | | 2018 Annual Base Salary | | | Percentage Change from 2018 Annual Base Salary to 2019 Annual Base Salary | |
| Victoria M. Holt | | | $600,000 | | | $550,000 | | | 9%(1) | |
| John A. Way | | | $362,436 | | | $351,880 | | | 3% | |
| Arthur R. Baker III | | | $312,312 | | | $300,300 | | | 4% | |
| Robert Bodor | | | $324,492 | | | $300,456 | | | 8%(1) | |
| Bjoern Klaas | | | $322,390 | | | $— | | | —%(2) | |
| David M. Fein | | | $367,710 | | | $360,500 | | | 2% | |
(1) | The percentage change from 2018 annual base salary to 2019 annual base salary was greater for Ms. Holt and Dr. Bodor than for our other named executive officers in order to remain market competitive. |
(2) | Mr. Klaas’ employment with us did not begin until December 2017. As a result, Mr. Klaas did not receive an increase from 2018 annual base salary to 2019 annual base salary. |
• | 75% of the annual bonus target was based on annual revenue growth, calculated without regard to foreign currency exchange rates. We refer to this aspect of the annual incentive program as the revenue factor. |
• | 25% of the annual bonus target was based on budgeted adjusted operating margin. We refer to this aspect of the annual incentive program as the adjusted operating income (“AOI”) factor. For purposes of calculating attainment of the AOI portion of the annual incentives, AOI is defined as operating income before incentive compensation expense, stock-based compensation expense, amortization expense, acquisition expenses and other one-time expenses not indicative of core operations, calculated as a percentage of revenue. |
| Name | | | Revenue | | | AOI | | ||||||
| Consolidated | | | Geographic Unit | | | Consolidated | | | Geographic Unit | | |||
| Victoria M. Holt | | | 100% | | | | | 100% | | | | ||
| John A. Way | | | 100% | | | | | 100% | | | | ||
| Arthur R. Baker III | | | 100% | | | | | 100% | | | | ||
| Robert Bodor | | | 35% | | | 65% | | | 100% | | | | |
| Bjoern Klaas | | | 35% | | | 65% | | | 100% | | | | |
| David M. Fein | | | 100% | | | | | 100% | | | |
| Name | | | Target Payout as % of 2019 Salary | |
| Victoria M. Holt | | | 100% | |
| John A. Way | | | 75% | |
| Arthur R. Baker III | | | 50% | |
| Robert Bodor | | | 60% | |
| Bjoern Klaas | | | 50% | |
| David M. Fein | | | 75% | |
• | For consolidated revenue performance between threshold and target, the payout factor would increase proportionately between 30% and 100%, or about 1.3 percentage points for each $1 million in additional consolidated revenue, and between target and maximum, the payout factor would increase proportionately between 100% and 200%, or about 1.7 percentage points for each $1 million in additional consolidated revenue. |
• | For United States revenue performance between threshold and target, the payout factor would increase proportionately between 30% and 100%, or about 1.6 percentage points for each $1 million in additional United States revenue, and between target and maximum, the payout factor would increase proportionately between 100% and 200%, or about 1.9 percentage points for each $1 million in additional consolidated revenue. |
• | For EMEA revenue performance between threshold and target, the payout factor would increase proportionately between 30% and 100%, or about 10.1 percentage points for each $1 million in additional EMEA revenue, and between target and maximum, the payout factor would increase proportionately between 100% and 200%, or about 9.6 percentage points for each $1 million in additional consolidated revenue. |
| Objective(1) | | | 2019 Target Growth (%) | | | 2019 Target Amount ($) | |
| Consolidated Revenue Growth | | | 17.1% | | | $520.0M | |
| United States Revenue Growth | | | 18.3% | | | $414.9M | |
| EMEA Revenue Growth | | | 13.0% | | | $90.6M | |
| Adjusted Operating Income | | | 25.9% | | | | |
(1) | The final payout factor for 2019 was based on the dollar amount of actual performance, as opposed to the growth percentage. |
| Objective | | | Actual Performance(1) | | | Final Payout Factor(6) | |
| Consolidated Revenue(2) | | | $461.2M | | | 21.3%(3) | |
| United States Revenue(4) | | | $360.4M | | | 15.3% | |
| EMEA Revenue(5) | | | $85.4M | | | 47.6% | |
| Adjusted Operating Income | | | 22.1% | | | 20.3% | |
(1) | Our actual performance is equal to our 2019 revenue calculated using 2019 budgeted foreign currency exchange rates. Actual AOI performance is listed as adjusted operating margin achieved in 2019. |
(2) | For consolidated revenue performance between threshold and target, the payout factor would increase proportionately between 30% and 100%, or about 1.3 percentage points for each $1 million in additional consolidated revenue. |
(3) | The final payout factor represents the percentage of the target payout that would be made based on the actual company-wide or business unit revenue for 2019, without regard to foreign currency exchange rates. Including the impact of foreign currency exchange rates would not have impacted the incentive for each named executive officer. |
(4) | For United States revenue performance between threshold and target, the payout factor would increase proportionately between 30% and 100%, or about 1.6 percentage points for each $1 million in additional United States revenue. |
(5) | For EMEA revenue performance between threshold and target, the payout factor would increase proportionately between 30% and 100%, or about 10.1 percentage points for each $1 million in additional EMEA revenue. |
(6) | Actual performance was below the threshold amount for the final payout factor. The Compensation Committee approved adjusting the Final Payout Factor to extend the calculation below the threshold amount. |
| Name | | | 2019 Actual Incentive Amount ($) | | | Percent of Annual Incentive Target Achieved (%) | |
| Victoria M. Holt | | | $215,308 | | | 36.0% | |
| John A. Way | | | $97,748 | | | 36.0% | |
| Arthur R. Baker III | | | $56,133 | | | 36.0% | |
| Robert Bodor | | | $59,941 | | | 33.0% | |
| Bjoern Klaas | | | $112,925 | | | 70.2% | |
| David M. Fein | | | $— | | | — | |
| Name | | | 2019 Actual Salary Amount | | | 2019 Actual Incentive Amount | | | 2019 Total Cash Compensation Amount | |
| Victoria M. Holt | | | $600,000 | | | $215,308 | | | $815,308 | |
| John A. Way | | | $362,436 | | | $97,748 | | | $460,184 | |
| Arthur R. Baker III | | | $312,312 | | | $56,133 | | | $368,445 | |
| Robert Bodor | | | $324,492 | | | $59,941 | | | $384,433 | |
| Bjoern Klaas | | | $322,390 | | | $112,925 | | | $445,315 | |
| David M. Fein | | | $367,710 | | | $— | | | $367,710 | |
| Name | | | Aggregate Grant Date Fair Value of 2019 Equity Awards | | | Number of RSUs Awarded | | | Number of Stock Options Awarded | | | Target Number of PSUs Awarded | |
| Victoria M. Holt | | | $ 2,500,203 | | | 6,287 | | | 7,120 | | | 14,288 | |
| John A. Way | | | $900,199 | | | 4,244 | | | 4,806 | | | 2,144 | |
| Arthur R. Baker III | | | $600,062 | | | 2,829 | | | 3,204 | | | 1,429 | |
| Robert Bodor | | | $600,062 | | | 2,829 | | | 3,204 | | | 1,429 | |
| Bjoern Klaas | | | $400,077 | | | 1,886 | | | 2,136 | | | 953 | |
| David Fein | | | $500,122 | | | 2,358 | | | 2,670 | | | 1,191 | |
| Relative TSR Percentile | | | PSU Payout (% of Target) | |
| Below 25th percentile | | | 0% | |
| 25th percentile | | | 50% | |
| 50th percentile | | | 100% | |
| 75th percentile or greater | | | 150% | |
(1) | All of the following factors are present: |
• | We are required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws; |
• | The award, vesting or payment of the incentive compensation was predicated upon the achievement of certain financial results that were the subject of the restatement and such award, vesting or payment occurred or was received during the three-year period preceding the date on which we were required to prepare the restatement; and |
• | A smaller award, vesting or payment would have occurred or been made to the executive officer based upon the restated financial results. |
(2) | There has been misconduct resulting in either a violation of law or of our company policy that has caused significant financial or reputational harm to our company and either the executive officer committed the misconduct or failed in his or her responsibility to manage or monitor the applicable conduct or risks. |
• | CEO – Five times annual base salary |
• | All other executive officers – One times annual base salary |
| Name and Principal Position | | | Year | | | Salary ($) | | | Stock Awards ($)(1) | | | Option Awards ($)(2) | | | Non-Equity Incentive Plan Compensation ($)(3) | | | All Other Compensation ($)(4) | | | Total ($) | |
| Victoria M. Holt President and Chief Executive Officer | | | 2019 | | | 600,000 | | | 2,160,169 | | | 340,034 | | | 215,308 | | | 11,000 | | | 3,326,511 | |
| 2018 | | | 550,000 | | | 2,160,155 | | | 340,025 | | | 534,875 | | | 11,000 | | | 3,596,055 | | |||
| 2017 | | | 530,450 | | | 2,250,089 | | | 250,065 | | | 597,154 | | | 10,800 | | | 3,638,558 | | |||
| John A. Way Chief Financial Officer | | | 2019 | | | 362,436 | | | 670,677 | | | 229,523 | | | 97,748 | | | 11,000 | | | 1,371,384 | |
| 2018 | | | 351,880 | | | 596,113 | | | 204,034 | | | 256,740 | | | 11,000 | | | 1,419,767 | | |||
| 2017 | | | 335,124 | | | 562,786 | | | 187,618 | | | 282,949 | | | 10,800 | | | 1,379,277 | | |||
| Arthur R. Baker III Chief Technology Officer | | | 2019 | | | 312,312 | | | 447,048 | | | 153,014 | | | 56,133 | | | 11,000 | | | 979,507 | |
| 2018 | | | 300,300 | | | 447,111 | | | 153,014 | | | 146,021 | | | 11,000 | | | 1,057,446 | | |||
| 2017 | | | 286,000 | | | 375,191 | | | 125,033 | | | 160,982 | | | 10,800 | | | 958,006 | | |||
| Robert Bodor Vice President/General Manager – Americas | | | 2019 | | | 324,492 | | | 447,048 | | | 153,014 | | | 59,941 | | | 11,000 | | | 995,495 | |
| 2018 | | | 300,456 | | | 417,290 | | | 142,838 | | | 174,965 | | | 11,000 | | | 1,046,549 | | |||
| 2017 | | | 278,200 | | | 375,191 | | | 125,033 | | | 172,324 | | | 10,800 | | | 961,548 | | |||
| Bjoern Klaas(5) Vice President and Managing Director - Europe, Middle East and Africa | | | 2019 | | | 322,390 | | | 298,066 | | | 102,011 | | | 112,925 | | | 13,863 | | | 849,255 | |
| | | | | | | | | | | | | | | | | | | | ||||
| | | | | | | | | | | | | | | | | | | | ||||
| David M. Fein(6) Former Chief Revenue Officer | | | 2019 | | | 163,833 | | | 372,609 | | | 127,513 | | | — | | | 419,942(7) | | | 1,083,897 | |
| 2018 | | | 360,500 | | | 372,663 | | | 127,527 | | | 262,940 | | | 11,000 | | | 1,134,630 | | |||
| 2017 | | | 350,000 | | | 375,191 | | | 125,033 | | | 295,509 | | | 10,800 | | | 1,156,533 | |
(1) | Amounts shown in this column reflect the aggregate grant date fair value of the RSUs and PSUs (at target) granted in 2019, 2018 and 2017 and are computed in accordance with ASC Topic 718, Compensation—Stock Compensation (ASC 718), based on the closing stock price on the grant date. The grant date fair value of RSUs granted in 2019 and the grant date fair value of the PSUs granted in 2019 if target performance and maximum performance is achieved are as follows: |
| Name | | | RSUs | | | PSUs | | |||
| | | | | Target | | | Maximum | | ||
| Victoria M. Holt | | | $660,072 | | | $1,500,097 | | | $2,250,146 | |
| John A. Way | | | $445,578 | | | $225,099 | | | $337,649 | |
| Arthur R. Baker III | | | $297,017 | | | $150,031 | | | $225,047 | |
| Robert Bodor | | | $297,017 | | | $150,031 | | | $225,047 | |
| Bjoern Klaas | | | $198,011 | | | $100,055 | | | $150,083 | |
| David M. Fein | | | $247,566 | | | $125,043 | | | $187,565 | |
(2) | Amounts shown in this column represent the grant date fair values computed in accordance with ASC 718 utilizing the assumptions discussed in Note 12 to our Consolidated Financial Statements for the year ended December 31, 2019 contained in our Annual Report on Form 10-K for the year ended December 31, 2019, and disregarding the effects of any estimates of forfeitures related to service-based vesting. |
(3) | Amounts shown in this column represent amounts earned under our annual incentive program during each respective year and paid early in the following year. |
(4) | Except for Mr. Klaas and Mr. Fein, amounts shown in this column for all named executive officers for 2019 represent company contributions to our 401(k) retirement plan. |
(5) | Prior to 2019, Mr. Klaas was not a named executive officer. |
(6) |
(7) | Amount includes $412,710 in cash severance payments, and $7,232 in premiums for COBRA continuation coverage. |
| | | | | Compensation Committee | | | Estimated Future Payouts Under Non-Equity Incentive Plan Awards(2) | | | Estimated Future Payouts Under Equity Incentive Plan Awards(3) | | | All Other Stock Awards: Number of Shares of Stock or Units (#)(4) | | | All Other Option Awards: Number of Securities Underlying Options (#)(5) | | | Exercise or Base Price of Option Awards ($/Sh) | | | Grant Date Fair Value of Stock and Option Awards(6) | | ||||||||||||||
| Name | | | Grant Date | | | Approval Date(1) | | | Threshold ($) | | | Target ($) | | | Maximum ($) | | | Threshold (#) | | | Target (#) | | | Maximum (#) | | ||||||||||||
| Victoria M. Holt | | | $195,000 | | | $ 600,000 | | | $1,200,000 | | | | | | | | | | | | | | | | |||||||||||||
| | | | | | | — | | | $90,000 | | | — | | | | | | | | | | | | | | | | ||||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | 6,287 | | | | | | | $660,072 | | |||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | | | 7,120 | | | 104.99 | | | $340,034 | | ||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | 7,144 | | | 14,288 | | | 21,432 | | | | | | | | | $ 1,500,097 | | |||||||
| John A. Way | | | $88,344 | | | $ 271,827 | | | $543,654 | | | | | | | | | | | | | | | | |||||||||||||
| | | | | | | — | | | $40,774 | | | — | | | | | | | | | | | | | | | | ||||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | 4,244 | | | | | | | $445,578 | | |||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | | | 4,806 | | | 104.99 | | | $229,523 | | ||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | 1,072 | | | 2,144 | | | 3,216 | | | | | | | | | $225,099 | | |||||||
| Arthur R. Baker III | | | $50,751 | | | $ 156,156 | | | $312,312 | | | | | | | | | | | | | | | | |||||||||||||
| | | | | | | — | | | $23,423 | | | — | | | | | | | | | | | | | | ||||||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | 2,829 | | | | | | | $297,017 | | |||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | | | 3,204 | | | 104.99 | | | $153,014 | | ||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | 715 | | | 1,429 | | | 2,144 | | | | | | | | | $150,031 | | |||||||
| Robert Bodor | | | $63,276 | | | $ 194,695 | | | $389,390 | | | | | | | | | | | | | | | | |||||||||||||
| | | | | | | — | | | $29,204 | | | — | | | | | | | | | | | | | | | | ||||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | 2,829 | | | | | | | $297,017 | | |||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | | | 3,204 | | | 104.99 | | | $153,014 | | ||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | 715 | | | 1,429 | | | 2,144 | | | | | | | | | $150,031 | | |||||||
| Bjoern Klaas | | | $52,388 | | | $ 161,195 | | | $322,390 | | | | | | | | | | | | | | | | |||||||||||||
| | | | | | | — | | | $24,179 | | | — | | | | | | | | | | | | | | | | ||||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | 1,886 | | | | | | | $198,011 | | |||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | | | 2,136 | | | 104.99 | | | $102,011 | | ||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | 477 | | | 953 | | | 1,430 | | | | | | | | | $100,055 | | |||||||
| David M. Fein | | | $89,629 | | | $275,783 | | | $551,565 | | | | | | | | | | | | | | | | |||||||||||||
| | | | | | | — | | | $41,367 | | | — | | | | | | | | | | | | | | | | ||||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | 2,358 | | | | | | | $247,566 | | |||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | | | | | | | | | 2,670 | | | 104.99 | | | $127,513 | | ||||||||
| | | 2/11/2019 | | | 2/5/2019 | | | | | | | | | 596 | | | 1,191 | | | 1,787 | | | | | | | | | $125,043 | |
(1) | In accordance with the terms of our equity grant timing policy, the RSUs, PSUs and stock option grants to our named executive officers identified in the table were granted effective as of the end of the second trading day following the public release of our financial results for the fourth quarter of 2018, even though the compensation committee approved the grants on an earlier date. |
(2) | As discussed above in “Compensation Discussion and Analysis—Elements of Executive Compensation—Annual Incentive Program,” amounts paid under our annual incentive program for 2019 were based in part on our revenue growth and AOI for the year. In addition, named executive officers also had the opportunity to earn an additional 15% annual incentive payment if pre-set milestones relating to a critical software project were achieved. The actual annual cash incentive amounts earned in connection with 2019 awards are reported in the Summary Compensation Table. |
(3) | As discussed above in “Compensation Discussion and Analysis—Elements of Executive Compensation,” amounts in this column represent an award of PSUs under the LTIP capable of being earned and vesting at the end of a three-year performance period depending on our company’s organic revenue and adjusted EPS performance in the final year of the performance period and the award recipient’s continued employment. The PSU vesting terms in the event of certain terminations of employment or a change in control of our company are described above in “Elements of Executive Compensation—Long-Term Equity-Based Compensation.” No dividend equivalents are paid on the PSUs. |
(4) | Amounts in this column represent awards of RSUs under the LTIP which vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Unvested RSUs will immediately vest in full upon the named executive officer’s death or disability and if, within one year of a change in control, the named executive officer’s employment is terminated without cause or for good reason. No dividend equivalents are paid on the RSUs. |
(5) | Amounts in this column represent awards of stock options under the LTIP which vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Unvested options will immediately become vested and exercisable in full upon the named executive officer’s death or disability and if, within one year of a change in control, the named executive officer’s employment is terminated without cause or for good reason. |
(6) | The actual value to be realized by a named executive officer depends upon the appreciation in value of our stock and the length of time the award is held. No value will be realized with respect to any stock option award if our stock price does not increase following the grant date. For a description of the assumptions used in computing grant date fair value for stock option awards pursuant to ASC 718, see Note 12 to our Consolidated Financial Statements for the year ended December 31, 2019 contained in our Annual Report on Form 10-K. The grant date fair value of each RSU award and PSU award (at target) was computed in accordance with ASC 718 based on the closing stock price on the grant date. |
| | | Option Awards | | | Stock Awards | | ||||||||||||||||||||||
| Name | | | Option Grant Date(1) | | | Number of Securities Underlying Unexercised Options (#) Exercisable | | | Number of Securities Underlying Unexercised Options (#) Unexercisable | | | Option Exercise Price ($/Sh) | | | Option Expiration Date | | | Number of Shares or Units of Stock That Have Not Vested (#) | | | Market Value of Shares or Units of Stock That Have Not Vested ($)(2) | | | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#) | | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(2) | |
| Victoria M. Holt | | | 02/09/15 | | | 14,392 | | | 3,598 | | | 67.15 | | | 02/09/25 | | | | | | | | | | ||||
| | | 02/08/16 | | | 11,346 | | | 7,564 | | | 57.88 | | | 02/08/26 | | | | | | | | | | |||||
| | | 02/13/17 | | | 3,628 | | | 5,442 | | | 58.35 | | | 02/13/27 | | | | | | | | | | |||||
| | | 02/12/18 | | | 1,787 | | | 5,364 | | | 105.75 | | | 02/12/28 | | | | | | | | | | |||||
| | | 02/11/19 | | | — | | | 7,120 | | | 104.99 | | | 02/11/29 | | | | | | | | | | |||||
| | | | | | | | | | | | | 939 | | | 95,355 | | | | | | ||||||||
| | | | | | | | | | | | | 3,456 | | | 350,957 | | | | | | ||||||||
| | | | | | | | | | | | | 7,713 | | | 783,255 | | | | | | ||||||||
| | | | | | | | | | | | | 4,682 | | | 475,457 | | | | | | ||||||||
| | | | | | | | | | | | | 6,287 | | | 638,445 | | | | | | ||||||||
| | | | | | | | | | | | | 23,077(3) | | | 2,343,469 | | | | | | | |||||||
| | | | | | | | | | | | | | | | | 14,186 | | | $ 1,440,588(4) | | ||||||||
| | | | | | | | | | | | | | | | | 14,288 | | | $ 1,450,946(5) | | ||||||||
| John A. Way | | | 12/01/14 | | | 2,608 | | | — | | | 62.90 | | | 12/01/24 | | | | | | | | | | ||||
| | | 02/09/15 | | | 2,996 | | | 1,999 | | | 67.15 | | | 02/09/25 | | | | | | | | | | |||||
| | | 02/08/16 | | | 5,511 | | | 5,674 | | | 57.88 | | | 02/08/26 | | | | | | | | | | |||||
| | | 02/13/17 | | | 2,722 | | | 4,083 | | | 58.35 | | | 02/13/27 | | | | | | | | | | |||||
| | | 02/12/18 | | | 1,072 | | | 3,219 | | | 105.75 | | | 02/12/28 | | | | | | | | | | |||||
| | | 02/11/19 | | | — | | | 4,806 | | | 104.99 | | | 02/11/29 | | | | | | | | | | |||||
| | | | | | | | | | | | | 522 | | | 53,009 | | | | | | ||||||||
| | | | | | | | | | | | | 2,592 | | | 263,218 | | | | | | ||||||||
| | | | | | | | | | | | | 5,787 | | | 587,670 | | | | | | ||||||||
| | | | | | | | | | | | | 2,809 | | | 285,254 | | | | | | ||||||||
| | | | | | | | | | | | | 4,244 | | | 430,978 | | | | | | ||||||||
| | | | | | | | | | | | | 15,954(6) | | | 1,620,129 | | | | | | ||||||||
| | | | | | | | | | | | | | | | | 1,892 | | | $ 192,133(4) | | ||||||||
| | | | | | | | | | | | | | | | | 2,144 | | | $217,723(5) | | ||||||||
| Arthur R. Baker III | | | 05/02/16 | | | 1,737 | | | 3,474 | | | 60.96 | | | 05/02/26 | | | | | | | | | | ||||
| | | 02/13/17 | | | 1,814 | | | 2,721 | | | 58.35 | | | 02/13/27 | | | | | | | | | | |||||
| | | 02/12/18 | | | 804 | | | 2,414 | | | 105.75 | | | 02/12/28 | | | | | | | | | | |||||
| | | 02/11/19 | | | — | | | 3,204 | | | 104.99 | | | 02/11/29 | | | | | | | | | | |||||
| | | | | | | | | | | | | 1,642 | | | 166,745 | | | | | | ||||||||
| | | | | | | | | | | | | 3,858 | | | 391,780 | | | | | | ||||||||
| | | | | | | | | | | | | 2,107 | | | 213,966 | | | | | | ||||||||
| | | | | | | | | | | | | 2,829 | | | 287,285 | | | | | | ||||||||
| | | | | | | | | | | | | 10,436(7) | | | 1,059,776 | | | | | | ||||||||
| | | | | | | | | | | | | | | | | 1,420 | | | $144,201(4) | | ||||||||
| | | | | | | | | | | | | | | | | 1,429 | | | $145,115(5) | | ||||||||
| Robert Bodor | | | 02/13/14 | | | 1,632 | | | — | | | 78.59 | | | 02/13/24 | | | | | | | | | | ||||
| | | 02/09/15 | | | 1,999 | | | 1,999 | | | 67.15 | | | 02/09/25 | | | | | | | | | | |||||
| | | 02/08/16 | | | 1,891 | | | 3,782 | | | 57.88 | | | 02/08/26 | | | | | | | | | | |||||
| | | 02/13/17 | | | 907 | | | 2,721 | | | 58.35 | | | 02/13/27 | | | | | | | | | | |||||
| | | 02/12/18 | | | 751 | | | 2,253 | | | 105.75 | | | 02/12/28 | | | | | | | | | | |||||
| | | 02/11/19 | | | — | | | 3,204 | | | 104.99 | | | 02/11/29 | | | | | | | | | | |||||
| | | | | | | | | | | | | 522 | | | 53,009 | | | | | | ||||||||
| | | | | | | | | | | | | 1,728 | | | 175,478 | | | | | | ||||||||
| | | | | | | | | | | | | 3,858 | | | 391,780 | | | | | | ||||||||
| | | | | | | | | | | | | 1,967 | | | 199,749 | | | | | | ||||||||
| | | | | | | | | | | | | 2,829 | | | 287,285 | | | | | | ||||||||
| | | | | | | | | | | | | 10,904(8) | | | 1,107,301 | | | | | | ||||||||
| | | | | | | | | | | | | | | | | 1,324 | | | $134,452(4) | | ||||||||
| | | | | | | | | | | | | | | | | 1,429 | | | $145,115(5) | |
| | | Option Awards | | | Stock Awards | | ||||||||||||||||||||||
| Name | | | Option Grant Date(1) | | | Number of Securities Underlying Unexercised Options (#) Exercisable | | | Number of Securities Underlying Unexercised Options (#) Unexercisable | | | Option Exercise Price ($/Sh) | | | Option Expiration Date | | | Number of Shares or Units of Stock That Have Not Vested (#) | | | Market Value of Shares or Units of Stock That Have Not Vested ($)(2) | | | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#) | | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(2) | |
| Bjoern Klaas | | | 02/11/19 | | | — | | | 2,136 | | | 104.99 | | | 02/11/29 | | | | | | | | | | ||||
| | | | | | | | | | | | | 3,177 | | | 322,624 | | | | | | ||||||||
| | | | | | | | | | | | | 1,886 | | | 191,523 | | | | | | ||||||||
| | | | | | | | | | | | | 5,063(9) | | | 514,148 | | | | | | ||||||||
| | | | | | | | | | | | | | | | | 953 | | | $96,777(5) | |
(1) | The option awards granted prior to 2018 vest as to 20% of the shares subject to each award in five annual installments on February 13 each year, with the exception of Mr. Way’s December 1, 2014 grant and Mr. Baker’s May 2, 2016 grant. Mr. Way and Mr. Baker’s awards vest on each of the first, second, third, fourth and fifth anniversaries of the date of grant. The option awards granted beginning in 2018 vest as to 25% of the shares subject to each award in four annual installments on February 13 each year. |
(2) | Based on the $101.55 per share closing price of our common stock on the NYSE on December 31, 2019. |
(3) | In the order presented in the table, the RSUs listed vest as to 939 shares subject to the units on February 13, 2020, as to 1,728 shares subject to the units on each of February 13, 2020 and 2021, as to 2,571 shares subject to the units on each of February 13, 2020, 2021 and 2022, as to 1,560 shares subject to the units on each of February 13, 2020, 2021 and 2022, and as to 1,571 shares subject to the units on each of February 13, 2020, 2021, 2022, 2023. |
(4) | Performance stock units vest on December 31, 2020 depending on our company's organic revenue and adjusted EPS performance in the final year of the performance period and the award recipients continued employment. |
(5) | Performance stock units vest on December 31, 2021 depending on our company's organic revenue and adjusted EPS performance in the final year of the performance period and the award recipients continued employment. |
(6) | In the order presented in the table, the RSUs listed vest as to 522 shares subject to the units on February 13, 2020, as to 1,296 shares subject to the units on each of February 13, 2020 and 2021, as to 1,929 shares subject to the units on each of February 13, 2020, 2021 and 2022, as to 936 shares subject to the units on each of February 13, 2020, 2021 and 2022 and as to 1,061 shares subject to the units on each of February 13, 2020, 2021, 2022 and 2023. |
(7) | In the order presented in the table, the RSUs listed vest as to 821 shares subject to the units on each of May 4, 2020 and 2021, as to 1,286 shares subject to the units on each of February 13, 2020, 2021 and 2022, as to 702 shares subject to the units on each of February 13, 2020, 2021 and 2022, and as to 707 shares subject to the units on each of February 13, 2020, 2021, 2022, and 2023. |
(8) | In the order presented in the table, the RSUs listed vest as to 522 shares subject to the units on February 13, 2020, as to 864 shares subject to the units on each of February 13, 2020 and 2021, as to 1,286 shares subject to the units on each of February 13, 2020, 2021 and 2022, as to 655 shares subject to the units on each of February 13, 2020, 2021 and 2022, and as to 707 shares subject to the units on each of February 13, 2020, 2021, 2022, 2023. |
(9) | In the order presented in the table, the RSUs listed vest as to 1,059 shares subject to the units on each of December 1, 2020, 2021 and 2022, and as to 471 shares subject to the units on each of February 13, 2020, 2021, 2022 and 2023. |
| | | Option Awards | | | Stock Awards | | |||||||
| Name | | | Number of Shares Acquired on Exercise (#) | | | Value Realized on Exercise ($)(1) | | | Number of Shares Acquired on Vesting (#) | | | Value Realized on Vesting ($)(2) | |
| Victoria M. Holt | | | — | | | — | | | 13,911(3) | | | 1,459,704(3) | |
| John A. Way | | | — | | | — | | | 5,319 | | | 568,913 | |
| Arthur R. Baker III | | | — | | | — | | | 2,809 | | | 306,400 | |
| Robert Bodor | | | — | | | — | | | 3,773 | | | 409,257 | |
| Bjoern Klaas | | | — | | | — | | | 1,059 | | | 101,484 | |
| David Fein | | | 3,839 | | | 131,901 | | | 3,070 | | | 330,524 | |
(1) | The value realized on exercise is calculated as the difference between the closing price of our common stock on the date of exercise as reported by the New York Stock Exchange for the number of shares acquired upon exercise and the applicable option exercise price for those shares. |
(2) | The value realized on vesting is calculated by multiplying the number of shares vested by the closing price of our common stock on the vesting date as reported by the New York Stock Exchange. |
(3) | Includes vested RSUs and the PSUs earned for the 2017-2019 performance period that ended on December 31, 2019 based on achievement of the performance goals. The value shown as realized on December 31, 2019 is based on the number of shares earned for the 2017-2019 performance period using the per share closing market price of our common stock on December 31, 2019, although shares were not issued until the Compensation Committee certified the performance results on March 9, 2020. |
• | we will pay Ms. Holt an amount equal to one times her annualized base salary in substantially equal installments in accordance with our regular payroll practices over the 12-month period immediately following the termination date, subject to limited exceptions; |
• | we will pay Ms. Holt an amount equal to one times her target annual cash incentive payment for the calendar year in which her employment with us terminates, payable in a lump sum; |
• | we will pay our share of premiums due for Ms. Holt and her eligible dependents for the first 12 months of coverage under COBRA if elected by Ms. Holt; and |
• | if Ms. Holt has any unvested equity-based awards as of the termination date, a pro rata portion of any unvested awards scheduled to vest on the next anniversary of the grant date will vest immediately. |
• | we will pay Ms. Holt an amount equal to two times her annualized base salary in substantially equal installments in accordance with our regular payroll practices over the 24-month period immediately following the termination date, subject to limited exceptions; |
• | we will pay Ms. Holt an amount equal to two times her target annual cash incentive payment for the calendar year in which her employment with us terminates, payable in a lump sum; |
• | we will pay our share of premiums due for Ms. Holt and her eligible dependents for the first 18 months of coverage under COBRA if elected by Ms. Holt; and |
• | if Ms. Holt has any unvested equity-based awards as of the termination date, all such unvested awards will vest immediately on Ms. Holt’s termination date. |
• | pay Ms. Holt an amount equal to one times her annualized base salary, payable in a lump sum; |
• | pay Ms. Holt an amount equal to one times her target annual cash incentive payment for the calendar year in which her employment with us terminates, payable in a lump sum; |
• | pay our share of premiums due for Ms. Holt and her eligible dependents for the first six months of coverage under COBRA if elected by Ms. Holt; and |
• | pay Ms. Holt an amount equal to the value of any unvested equity-based awards held by her as of the termination date that were forfeited as of the termination date. |
• | we will pay such officer an amount equal to his annualized base salary in substantially equal installments in accordance with our regular payroll practices over the 12-month period immediately following the termination date, subject to limited exceptions; |
• | we will pay such officer a pro rata cash incentive payment amount, payable in a lump sum; |
• | we will pay our share of premiums due for such officer and his eligible dependents for the first 12 months of coverage under COBRA; and |
• | if such officer has any unvested equity-based awards as of the termination date, a pro rata portion of any unvested awards scheduled to vest on the next anniversary of the grant date will vest immediately. |
• | we will pay such officer an amount equal to his annualized base salary in substantially equal installments in accordance with our regular payroll practices over the 12-month period immediately following the termination date, subject to limited exceptions; |
• | we will pay such officer an amount equal to the sum of (i) his target annual cash incentive payment for the calendar year in which his employment with us terminates plus (ii) a pro rata cash incentive payment amount, payable in a lump sum; |
• | we will pay our share of premiums due for such officer and his eligible dependents for the first 12 months of coverage under COBRA; and |
• | if such officer has any unvested equity-based awards as of the termination date, all such unvested awards will vest immediately on his termination date. |
• | pay such officer an amount equal to his target annual cash incentive payment for the calendar year in which his or her employment with us terminates, payable in a lump sum; and |
• | pay such officer an amount equal to the value of any unvested equity-based awards held by him as of the termination date that were forfeited as of the termination date. |
• | Arrange for the surviving or successor entity to continue, assume or replace some or all of the outstanding awards under the LTIP. |
• | Accelerate the vesting and exercisability of outstanding awards prior to and conditioned upon the occurrence of the event and provide that unexercised options and SARs will be terminated at the effective time of the event. |
• | Cancel any outstanding award in exchange for payment to the holder of the amount of the consideration that would have been received in the event for the number of shares subject to the award, less the aggregate exercise price (if any) of the award. |
• | Provide that if an award is continued, assumed or replaced in connection with such an event and if within 18 months after the event a participant experiences an involuntary termination of service other than for cause, the participant’s outstanding awards will vest in full, will immediately become fully exercisable and will remain exercisable for one year following termination. |
• | Make certain adjustments to awards as provided in the LTIP. |
| Name | | | Termination Without Cause or For Good Reason Not During Transition Period or in Anticipation of Change in Control | | | Termination Without Cause or For Good Reason Upon a Change in Control or During Transition Period(1) | | | Termination Without Cause or For Good Reason in Anticipation of Change in Control(2) | | | Death | | | Disability | | | Change in Control Without Termination | | | Retirement | |
| Victoria M. Holt | | | | | | | | | | | | | | | | |||||||
| Base Salary Payment | | | 600,000 | | | 1,200,000 | | | 600,000 | | | — | | | — | | | — | | | — | |
| Incentive Payment | | | 600,000 | | | 1,200,000 | | | 600,000 | | | 600,000 | | | 600,000 | | | — | | | — | |
| Benefits Continuation | | | 12,655 | | | 18,983 | | | 6,328 | | | — | | | — | | | — | | | — | |
| Accelerated Option Vesting | | | 323,019 | | | 689,185 | | | 689,185 | | | 689,185 | | | 689,185 | | | — | | | — | |
| Accelerated RSU Vesting | | | 747,511 | | | 2,343,469 | | | 2,343,469 | | | 2,343,469 | | | 2,343,469 | | | — | | | — | |
| Accelerated PSU Vesting(3) | | | — | | | — | | | — | | | 2,166,302 | | | — | | | — | | | — | |
| John A. Way | | | | | | | | | | | | | | | | |||||||
| Base Salary Payment | | | 362,436 | | | 362,436 | | | 362,436 | | | — | | | — | | | — | | | — | |
| Incentive Payment | | | 271,827 | | | 543,654 | | | 543,654 | | | — | | | — | | | — | | | — | |
| Benefits Continuation | | | 13,590 | | | 13,590 | | | 13,590 | | | — | | | — | | | — | | | — | |
| Accelerated Option Vesting | | | 221,140 | | | 492,935 | | | 492,935 | | | 492,935 | | | 492,935 | | | — | | | — | |
| Accelerated RSU Vesting | | | 512,987 | | | 1,620,129 | | | 1,620,129 | | | 1,620,129 | | | 1,620,129 | | | — | | | — | |
| Accelerated PSU Vesting(3) | | | — | | | — | | | — | | | 200,662 | | | — | | | — | | | — | |
| Arthur R. Baker III | | | | | | | | | | | | | | | | |||||||
| Base Salary Payment | | | 312,312 | | | 312,312 | | | 312,312 | | | — | | | — | | | — | | | — | |
| Incentive Payment | | | 156,156 | | | 312,312 | | | 312,312 | | | — | | | — | | | — | | | — | |
| Benefits Continuation | | | 4,637 | | | 4,637 | | | 4,637 | | | — | | | — | | | — | | | — | |
| Accelerated Option Vesting | | | 80,818 | | | 258,557 | | | 258,557 | | | 258,557 | | | 258,557 | | | — | | | — | |
| Accelerated RSU Vesting | | | 295,506 | | | 1,059,776 | | | 1,059,776 | | | 1,059,776 | | | 1,059,776 | | | — | | | — | |
| Accelerated PSU Vesting(3) | | | — | | | — | | | — | | | 144,506 | | | — | | | — | | | — | |
| Robert Bodor | | | | | | | | | | | | | | | | |||||||
| Base Salary Payment | | | 324,492 | | | 324,492 | | | 324,492 | | | — | | | — | | | — | | | — | |
| Incentive Payment | | | 194,695 | | | 389,390 | | | 389,390 | | | — | | | — | | | — | | | — | |
| Benefits Continuation | | | 5,469 | | | 5,469 | | | 5,469 | | | — | | | — | | | — | | | — | |
| Accelerated Option Vesting | | | 167,560 | | | 351,473 | | | 351,473 | | | 351,473 | | | 351,473 | | | — | | | — | |
| Accelerated RSU Vesting | | | 360,359 | | | 1,107,301 | | | 1,107,301 | | | 1,107,301 | | | 1,107,301 | | | — | | | — | |
| Accelerated PSU Vesting(3) | | | — | | | — | | | — | | | 138,007 | | | — | | | — | | | — | |
| Bjoern Klaas | | | | | | | | | | | | | | | | |||||||
| Base Salary Payment | | | 322,390 | | | 322,390 | | | 322,390 | | | — | | | — | | | — | | | — | |
| Incentive Payment | | | 161,195 | | | 322,390 | | | 322,390 | | | — | | | — | | | — | | | — | |
| Benefits Continuation | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
| Accelerated Option Vesting | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
| Accelerated RSU Vesting | | | 50,609 | | | 514,148 | | | 514,148 | | | 514,148 | | | 514,148 | | | — | | | — | |
| Accelerated PSU Vesting(3) | | | — | | | — | | | — | | | 32,259 | | | — | | | — | | | — | |
| | | | | | | | | | | | | |
(1) | The LTIP provides that, in connection with a change in control, we may, among other actions, (i) arrange for the surviving or successor entity to continue, assume or replace outstanding awards under the LTIP, (ii) accelerate the vesting and exercisability of outstanding awards upon the occurrence of the change in control or (iii) cancel outstanding awards in exchange for payment of the amount of consideration that would |
(2) | Pursuant to agreements between us and each of our named executive officers each such named executive officer is entitled to the payments and benefits summarized above if his or her employment terminates within 90 days prior to a change in control, and if the termination is without cause or for good reason and the executive reasonably demonstrates within 30 days after the change in control that the qualifying termination arose in connection with or in anticipation of the change in control. |
(3) | Upon termination of the executive officer’s employment by us without cause or by the executive for good reason or due to retirement or disability, a pro rata portion (based on the portion of the performance period that elapsed prior to the date of termination) of the number of PSUs that would have been earned at the end of the applicable performance periods if employment had continued will vest on the scheduled vesting date. Because the PSU awards are not accelerated under such circumstances, and because the determination regarding the number of outstanding PSUs to be earned cannot be made until after the applicable performance periods end on December 31, 2020 and December 31, 2021, no accelerated values for outstanding PSU awards are included in the table columns relating to retirement, disability and without cause and good reason terminations. In addition, as of December 31, 2019, none of our named executive officers were eligible for the retirement-based pro rata vesting of PSUs under the terms of their PSU awards. |
• | Increase in the value of the annual equity award from $140,000 to $145,000 in 2021. |
• | Increase in the expected ownership of our common stock from three times the amount of the annual board member retainer to five times the amount of the annual board member retainer. |
| Annual cash retainer: | | | $50,000 | |
| | | | ||
| Annual cash retainer for Chairman: | | | $50,000 | |
| | | | ||
| Annual cash retainer for committee chairs: | | | Audit Committee: $20,000 Compensation Committee: $15,000 Nominating and Governance Committee: $10,000 | |
| | | | ||
| Annual cash retainer for other committee members: | | | Audit Committee: $8,000 Compensation Committee: $6,000 Nominating and Governance Committee: $4,000 | |
| | | | ||
| Annual equity award: | | | $140,000 grant date fair value of restricted stock units or deferred stock units (at the director’s election) which become vested in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting of our shareholders (with such $140,000 value to be increased to $145,000 in 2021) | |
| | | | ||
| New director equity award: | | | Restricted stock units with $100,000 grant date fair value, granted on the date the director is first elected to the board | |
| | | | ||
| Meeting fees: | | | Generally none, but compensation committee has the discretion to provide for meeting fees if the number of board of directors meetings exceeds eight per year or if the number of meetings of any committee exceeds six per year | |
| Name | | | Fees Earned or Paid in Cash ($) | | | Stock Awards ($) | | | Option Awards ($) | | | Total | |
| Sven A. Wehrwein | | | 124,000 | | | 140,000 | | | — | | | 264,000 | |
| Archie C. Black | | | 56,000 | | | 140,000 | | | — | | | 196,000 | |
| Sujeet Chand | | | 60,000 | | | 140,000 | | | — | | | 200,000 | |
| Rainer Gawlick | | | 73,000 | | | 140,000 | | | — | | | 213,000 | |
| John B. Goodman | | | 68,000 | | | 140,000 | | | — | | | 208,000 | |
| Donald G. Krantz | | | 50,000 | | | 140,000 | | | — | | | 190,000 | |
| Moohnie Chin | | | 20,879 | | | 100,000 | | | — | | | 120,879 | |
| Name | | | Number of Shares Underlying Unexercised Options | | | Number of Shares Subject to Unvested DSUs | | | Number of Shares Subject to Unvested RSUs | |
| Archie C. Black | | | — | | | 1,311 | | | — | |
| Sujeet Chand | | | — | | | 1,311 | | | — | |
| Moonhie Chin | | | — | | | — | | | — | |
| Rainer Gawlick | | | 8,436 | | | 1,311 | | | — | |
| John B. Goodman | | | — | | | 1,311 | | | — | |
| Donald G. Krantz | | | — | | | — | | | 1,311 | |
| Sven A. Wehrwein | | | 10,817 | | | 1,311 | | | — | |
| THE BOARD, UPON RECOMMENDATION OF THE AUDIT COMMITTEE, UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE “FOR” THE RATIFICATION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL 2020. | |
| | | Fiscal Year(1) | | ||||
| | | 2019 | | | 2018 | | |
| Audit Fees | | | $957,043 | | | $956,387 | |
| Audit-Related Fees | | | — | | | 7,654 | |
| Tax Fees | | | — | | | — | |
| All Other Fees | | | — | | | — | |
| Total | | | $957,043 | | | $964,041 | |
| THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” THE ADVISORY (NONBINDING) RESOLUTION. | |
| THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR “ONE YEAR” AS THE PREFERRED FREQUENCY FOR FUTURE SAY-ON-PAY VOTES. | |